ORIGINAL RESEARCH article
Front. Genet.
Sec. Computational Genomics
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1614573
Analysis and Validation of Novel Biomarkers Related to Palmitoylation in Adenomyosis
Provisionally accepted- 1Department of Gynecology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu Province, China
- 2Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Chengguan, Gansu Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Adenomyosis, a common gynecological disorder in women of reproductive age, is characterized by endometrial invasion into the myometrium, leading to uterine enlargement and smooth muscle hypertrophy. Typical clinical symptoms include chronic pelvic pain, abnormal uterine bleeding, and infertility, which significantly impair patients' quality of life. Currently, effective diagnostic biomarkers for adenomyosis are lacking. Recent studies suggest that estrogen may promote Scribble protein depalmitoylation by upregulating APT1 and APT2 expression. Depalmitoylation facilitates Scribble's translocation from the cell membrane to the cytoplasm, disrupting endometrial epithelial cell polarity. This polarity loss may enhance abnormal proliferation, migration, and invasion of endometrial epithelial cells, promoting endometrial tissue infiltration into the myometrium and contributing to adenomyosis development and progression. Therefore, investigating adenomyosis diagnosis and treatment from the perspective of palmitoylation-related genes holds significant scientific importance.Methods In this study, four datasets, GSE244236, GSE190580, GSE185392 and GSE157718, were downloaded and the data were screened and standardized the data. First, GSE244236 was used as the training dataset. By integrating multiple bioinformatics approaches-including differential gene analysis (DEGs), weighted gene co-expression network analysis (WGCNA), Least Absolute Shrinkage (LASSO), random forest (RF) methods, and Support Vector Machine (SVM)-recursive feature elimination (SVM-RFE)-we identified three overlapping diagnostic genes through comprehensive analysis. Meanwhile, the diagnostic value of each biomarker was assessed using the subject work characteristic curve analysis in the remaining three datasets. In addition, single-sample gene set enrichment analysis (ssGSEA) were utilized to explore the infiltration of immune cells in adenomyosis and to examine the correlation between diagnostic biomarkers and immune cells.A total of 549 differentially expressed genes were identified in the analysis. Through WGCNA analysis, we obtained 25 palmitoylation-related intersecting genes. Using LASSO, RF and SVM-RFE algorithms, seven potential diagnostic genes were finally screened: LIPH, CYP2E1 and CHRNE.In this study, we successfully identified diagnostic biomarkers for adenomyosis using comprehensive bioinformatics analysis and machine learning methods, and validated them with column line plots and ROC curves. Our findings provide new perspectives for understanding the pathogenesis of palmitoylation-related genes in adenomyosis and offer potential targets for the development of new therapeutic strategies.
Keywords: palmitoylation, Adenomyosis, machine learning, Diagnostic model, Gene Expression
Received: 19 Apr 2025; Accepted: 14 Jul 2025.
Copyright: © 2025 Zhang, Li, Cao, Zhao, Qin and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hongyu Zhang, Department of Gynecology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.